Scribe Therapeutics

1 follower

‌

Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

Industries

Headquarters

Stage

Employees

Links

Org chart

View full screen

Benjamin L. Oakes

Co-Founder, President & CEO

Benjamin L. Oakes

Collapse

Brett T. Staahl

Co-Founder & VP, External Innovation

David Parrot

CFO

Svetlana Lucas

Chief Business Officer

Richard Hector

Head of IP

Vera Switek

VP, Talent

Sunny Mok

VP, Program Management

Kristina Oresic Bender

Vice President Translational Sciences

Shilpa Shroff

VP, Process Sciences

Michelle Eggers

Senior Director, Preclinical Study Management

Ed Sterling II

Director, Information Technology At Scribe Therapeutics

Teams

View all

Leadership Team

9 members

Founding Team

4 members

Board of Directors

3 members

CEO and Executive Team

3 members

Discover similar companies

Kyverna Therapeutics

2 followers

Werewolf Therapeutics

1 follower

Jnana Therapeutics

1 follower

Odyssey Therapeutics

2 followers

Arbor Biotechnologies

1 follower